We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
(+16%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
5.36%
Top 10 Holdings %
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$84.4M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$81.5M |
| 3 |
Valaris
VAL
|
+$24.1M |
| 4 |
CAI
CAI International, Inc.
CAI
|
+$12.6M |
| 5 |
STMP
Stamps.com, Inc.
STMP
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22.9M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$19.4M |
| 3 |
PFPT
Proofpoint, Inc.
PFPT
|
+$19M |
| 4 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$16.1M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.4% |
| 2 | Technology | 6.32% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 4.27% |
| 5 | Communication Services | 2.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Azenta
AZTA
$1.54B
| – | – |
-2,878
| Closed | -$274K |
|
1702
Boeing
BA
$184B
| – | – |
-2,516
| Closed | -$561K |
|
1703
Bank of America
BAC
$447B
| – | – |
-7,066
| Closed | -$291K |
|
|
1704
PUT
Bank of America
BAC
$447B
| – | – |
-74,400
| Closed | -$2.59M |
|
1705
Braskem
BAK
$889M
| – | – |
-9,600
| Closed | -$229K |
|
1706
CALL
Bath & Body Works
BBWI
$3.89B
| – | – |
-39,955
| Closed | -$2.33M |
|
|
1707
PUT
Bath & Body Works
BBWI
$3.89B
| – | – |
-23,256
| Closed | -$1.35M |
|
1708
Brink's
BCO
$4.55B
| – | – |
-3,278
| Closed | -$252K |
|
1709
Becton Dickinson
BDX
$48.9B
| – | – |
-4,755
| Closed | -$1.13M |
|
1710
KE Holdings
BEKE
$19.5B
| – | – |
-70,200
| Closed | -$3.35M |
|
1711
Franklin Resources
BEN
$17B
| – | – |
-22,672
| Closed | -$732K |
|
1712
Bread Financial
BFH
$4.38B
| – | – |
-25,079
| Closed | -$2.08M |
|
1713
CALL
B&G Foods
BGS
$276M
| – | – |
-93,800
| Closed | -$3.08M |
|
|
BBT
1714
Beacon Financial Corp
BBT
$2.66B
| – | – |
-74,085
| Closed | -$2.04M |
|
1715
Baidu
BIDU
$37.1B
| – | – |
-26,097
| Closed | -$5.32M |
|
1716
PUT
Biogen
BIIB
$30.6B
| – | – |
-3,000
| Closed | -$882K |
|
1717
Bilibili
BILI
$7.95B
| – | – |
-25,301
| Closed | -$3.08M |
|
|
BNY
1718
Bank of New York Mellon
BNY
$108B
| – | – |
-27,673
| Closed | -$1.42M |
|
1719
PUT
Baker Hughes
BKR
$63.6B
| – | – |
-10,000
| Closed | -$229K |
|
1720
Blue Bird Corp
BLBD
$2.07B
| – | – |
-32,321
| Closed | -$804K |
|
1721
Bloomin' Brands
BLMN
$944M
| – | – |
-33,621
| Closed | -$912K |
|
|
BLUE
1722
DELISTED
bluebird bio
BLUE
| – | – |
-523
| Closed | -$217K |
|
1723
Bumble
BMBL
$360M
| – | – |
-4,915
| Closed | -$283K |
|
1724
Badger Meter
BMI
$3.95B
| – | – |
-5,164
| Closed | -$507K |
|
1725
Bristol-Myers Squibb
BMY
$132B
| – | – |
-14,034
| Closed | -$924K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.
- Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
- Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
- Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
- Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
- Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
- Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
- Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.
Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.